SCN2A and Benign familial neonatal-infantile seizures: Missense mutations of SCN2A were also identified in a small percentage of GEFS+ patients and mainly in patients with benign familial neonatal-infantile seizures (BFNIS), a syndrome of mild seizures that remit during the first year of life without neurologic sequelae.